VoxelGrids Unveils India’s First Indigenous MRI Scanner

 



In a major boost to India’s medical technology ecosystem, Bengaluru-based start-up VoxelGrids has developed the country’s first fully indigenous MRI scanner. The milestone marks a significant step towards reducing India’s heavy dependence on imported diagnostic equipment and strengthening the “Made in India” push in high-end healthcare technology.

Breakthrough in Domestic Medical Imaging

The 1.5-tesla MRI scanner developed by “VoxelGrids” has been deployed at the Chandrapur Cancer Care Foundation near “Nagpur”. The system is the outcome of a 12-year effort led by founder “Arjun Arunachalam”, aimed at designing and manufacturing MRI technology entirely within India—an area traditionally dominated by global players.

Cost and Technology Advantages

Unlike conventional MRI machines produced by multinational firms such as “Siemens” and “GE HealthCare”, VoxelGrids’ scanner does not use liquid helium. This innovation reduces manufacturing costs by nearly 40 per cent. The company has also developed compact, energy-efficient electronics around the magnet while retaining standard bore size, significantly lowering power consumption and operating expenses.

Improving Access Through Flexible Models

VoxelGrids plans to offer pay-per-use pricing models, enabling hospitals to pay dynamically rather than bear high upfront capital costs. This approach could be especially beneficial for small and mid-sized hospitals. The move is timely, as India currently has only about 5,000 MRI machines—roughly 3.5 scanners per million people—highlighting a major diagnostic infrastructure gap.

Manufacturing Capacity and Future Plans

VoxelGrids currently has the capacity to manufacture 20–25 MRI scanners annually at its “Bengaluru” facility. Backed by $5 million in funding from “Zoho”, the start-up is preparing for a commercial launch by the end of the current financial year. Future plans include mobile, containerised MRI units and potential exports once domestic demand is addressed.

#VoxelGrids
#IndigenousMRI
#MadeInIndia
#MedicalImaging
#HealthcareInnovation
#IndianMedTech
#MRIInnovation
#AtmanirbharBharat
#DigitalHealthcare
#MedTechIndia

World Cell Biologist Awards: 

Website Link : cellbiologist.org 

Follow Us On : 
Tumblr ; tumblr.ccom/

Comments

Post a Comment

Popular posts from this blog

Uttrakhand Forest Department Establishes Mahabharata Vatika

Image
  The Uttarakhand Forest Department has established two gardens in Haldwani, showcasing plant species referenced in ancient Indian epics. These gardens, named Ramayana Vatika and Mahabharata Vatika, aim to highlight the ecological wisdom embedded in these texts. Mahabharata Vatika Overview Mahabharata Vatika spans one acre and features 37 plant species mentioned in the epic. Chief Conservator of Forests Sanjeev Chaturvedi emphasised the research behind selecting these species. The garden features important plant species such as: Ecological Significance The garden puts stress on the importance of forests as depicted in the Mahabharata. It references the Vana Parva, which discusses tree planting and wildlife conservation . The epic highlights the mutual dependence of tigers and forests, a concept vital to contemporary conservation efforts. Cultural Connections Chaturvedi brought into light that the Mahabharata teaches the spiritual significance of planting trees. He mentioned Bhish...
Read more

What is Zolgensma?

Image
  Spinal Muscular Atrophy (SMA) is a rare genetic disease affecting muscle function. In India, treatment options are limited, mainly due to high costs. The gene therapy drug, Zolgensma , costs around 16 crore rupees. Despite this, some families are finding ways to access treatment. About Spinal Muscular Atrophy (SMA) SMA is a genetic disorder that leads to the loss of motor neurons in the spinal cord. This results in muscle weakness and atrophy. Symptoms often appear in infancy. Children may struggle with basic movements like lifting their heads or crawling. Early diagnosis is crucial for effective treatment. About Zolgensma Zolgensma (onasemnogene abeparvovec-xioi) is a revolutionary gene therapy for SMA. It addresses the root cause by replacing the missing or defective SMN1 gene . This therapy can improve motor function in affected children. Although it is costly, it represents hope for many families. SMA is not as rare as once thought. The global prevalence is estimated at 1 in ...
Read more

CAR T-Cell Therapy for Cancer

Image
  India has recently made strides in cancer treatment with the introduction of CAR T-cell therapy . The results from the first clinical trials have been published in The Lancet, showcasing a remarkable success rate. This therapy is a game changer for patients with blood cancers. It offers hope to those who have exhausted other treatment options. What is CAR T-Cell Therapy? CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an innovative treatment that harnesses the body’s immune system. It trains T-cells to target and destroy cancer cells. This therapy is specifically designed for certain blood cancers. It is particularly beneficial for patients whose cancer has relapsed or failed to respond to standard treatments. Clinical Trial The clinical trials reported a response rate of nearly 73%. This indicates that number of patients benefited from the treatment. The trials also provided critical data on survival rates for patients with acute lymphoblastic leukaemia and l...
Read more